Acrigen Biosciences
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 4
About Acrigen Biosciences
Based in CA, US, and founded in 2019, Acrigen Biosciences, Inc. provides a pipeline of therapies to treat genetic disorders. The company develops Precision Gene Editing Systems which harness the power of CRISPR which is used in human therapeutics. Utilizing ErAcrs (engineered anti-CRISPR proteins) and revolutionary aCas and µCas CRISPR gene editors, Acrigen's unique technology develops an editing toolkit.
Who invested in Acrigen Biosciences
4 investors across 1 round
See all investors in Acrigen Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 28, 2021
Amount
Undisclosed
Investors
Questions about Acrigen Biosciences
Who invested in Acrigen Biosciences?
Acrigen Biosciences has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acrigen Biosciences raised?
Acrigen Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Acrigen Biosciences last raise money?
Acrigen Biosciences's most recent round on record is a Seed, in Sep 2021.
What does Acrigen Biosciences do?
Based in CA, US, and founded in 2019, Acrigen Biosciences, Inc.
Where is Acrigen Biosciences headquartered?
Acrigen Biosciences is headquartered in Alameda, US.
Which VCs invest in companies like Acrigen Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Acrigen Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Acrigen Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.